| Brand Name | Humira |
| Generic Name | Adalimumab |
| Drug Class | Anti-TNF-alpha Monoclonal Antibody |
| Availability | Prescription |
| Manufacturer | AbbVie |
| Indications | Ulcerative Colitis, Crohn's Disease |
| Type | Injection |
| Doses | 160 mg (induction), followed by 80 mg at week 2, then 40 mg every other week. |
| Route | Subcutaneous (SC) |
| Side Effects | Injection site reactions, rash, headache, increased risk of infections |
| Interactions | TNF-alpha blocker; increased risk of infections; avoid live vaccines |
| Overdose | Infection risk, fatigue. |
| Missed Dose | Inject ASAP; continue regular schedule. |
| Contraindications | Active infections, TB, hepatitis B, demyelinating disorders. |
| Alternatives | Adalimumab, Golimumab |
| Co-Pay Assistance Program | Available Rx |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Adalimumab is used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, Crohn�s disease, and ulcerative colitis.
Adalimumab works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a protein involved in the inflammatory process, thereby reducing inflammation and tissue damage.
Common side effects include injection site reactions, headaches, and upper respiratory infections. Serious side effects may include serious infections or blood disorders.
Adalimumab is administered as a subcutaneous injection, typically once every two weeks, depending on the condition being treated and the patient�s response.
Yes, Adalimumab is also used to treat Crohn�s disease, psoriasis, ulcerative colitis, ankylosing spondylitis, and other autoimmune diseases.
If you miss a dose, take it as soon as you remember unless it�s almost time for the next dose. Do not take two doses at once to make up for a missed dose.
Adalimumab may be used during pregnancy if the benefits outweigh the risks. It is important to discuss this with your healthcare provider if you are pregnant or planning to become pregnant.
Yes, Adalimumab can increase the risk of serious infections, including tuberculosis and fungal infections. Regular screening and monitoring are important while on treatment.
It may take several weeks to months for Adalimumab to show significant effects, especially in conditions like rheumatoid arthritis and Crohn�s disease.
Adalimumab may interact with other immunosuppressive drugs or biologics. Always inform your healthcare provider about all medications you are taking.
Related Conditions |
Related Blogs |
|---|---|
